PRESS RELEASE published on 01/18/2024 at 15:00, 1 year 10 months ago National Mobile Wound Care Clinic Selects Dr. Dennis Deruelle as Chief Medical Officer Dr. Dennis Deruelle has been appointed as the new Chief Medical Officer of Mendota Health, where he will lead a national mobile advanced wound care clinic to address the growing need for wound care in the United States. The impact of social determinants of health on wound care and the barriers to accessing medical services are highlighted, with a focus on providing quality care at home. Dr. Deruelle emphasizes the importance of nurse practitioners in wound care and their vital role in healthcare. For more information about Mendota Health, visit www.mendotahealth.com. Dr. Dennis Deruelle Mendota Health Wound Care Clinic Social Determinants Of Health Nurse Practitioners
Published on 12/18/2025 at 00:55, 3 hours 4 minutes ago Molten Metals Corp. Announces Flow-Through Financing
Published on 12/18/2025 at 00:00, 3 hours 59 minutes ago Right Season Investments Announces Name Change to FutureGen Industries Corp.
Published on 12/17/2025 at 23:15, 4 hours 44 minutes ago Northern Superior Announces the Ratio for the Distribution of the Common Shares in the Capital of ONGold Resources Ltd.
Published on 12/17/2025 at 15:00, 12 hours 59 minutes ago BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 13 hours 59 minutes ago UniDoc Completes H3 Health Cube Installation in Italy
Published on 12/18/2025 at 01:10, 2 hours 48 minutes ago Samsung To Unveil New AI-Connected Living Lineup at CES 2026
Published on 12/18/2025 at 00:50, 3 hours 8 minutes ago Historic production of graphene enhanced cement successfully completed
Published on 12/17/2025 at 22:05, 5 hours 54 minutes ago Abivax annonce l’acceptation de 22 abstracts sur obefazimod dans les MICI à l’ECCO 2026, dont une présentation orale sur des résultats précliniques antifibrotiques
Published on 12/17/2025 at 22:05, 5 hours 54 minutes ago Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
Published on 12/17/2025 at 21:22, 6 hours 37 minutes ago EQS-Adhoc: DATAGROUP SE: DATAGROUP SE Management Board plans dividend of EUR 0.04 per share
Published on 12/17/2025 at 20:39, 7 hours 20 minutes ago Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 20:39, 7 hours 20 minutes ago Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris
Published on 12/17/2025 at 19:30, 8 hours 29 minutes ago Evolution de la composition du Conseil d’Administration
Published on 12/17/2025 at 18:00, 9 hours 59 minutes ago Outstanding Shares and Voting Rights Statement at 30 November 2025